Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
By G. Khandaker, L. Cousins, J. Deakin, B. Lennox, R. Yolken, Peter B. Jones. Lancet psychiatry, 2015
756 citations recorded by the source corpus.
Complex interactions between the immune system and the brain might have important aetiological and therapeutic implications for neuropsychiatric brain disorders. A possible association between schizophrenia and the immune system was postulated over a century ago, and is supported by epidemiological and genetic studies pointing to links with infection and inflammation. Contrary to the traditional view that the brain is an immunologically privileged site shielded behind the blood–brain barrier, studies in the past 20 years have noted complex interactions between the immune system, systemic inflammation, and the brain, which can lead to changes in mood, cognition, and behaviour. In this Review, we describe some of the important areas of research regarding innate and adaptive immune response in schizophrenia and related psychotic disorders that, we think, will be of interest to psychiatric clinicians and researchers. We discuss potential mechanisms and therapeutic implications of these findings, including studies of anti-inflammatory drugs in schizophrenia, describe areas for development, and offer testable hypotheses for future investigations.
Subfields: Biological Psychiatry, Neurology, Social Psychology
View Paper: https://www.semanticscholar.org/paper/11bed9abb93baa9f63598b267b500775a9dfbdb2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
Citations in the corpus
- Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels (2019, background): “, 2001), schizophrenia (Miller et al., 2011; Khandaker et al., 2015) and dementias (Schmidt et al.”